Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway

Jing Ding,Min Yu,Juncai Jiang,Yanbei Luo,Qian Zhang,Shengnan Wang,Fei Yang,Alei Wang,Lingxiao Wang,Mei Zhuang,Shan Wu,Qifang Zhang,Yong Xia,Deqin Lu

DOI: https://doi.org/10.3389/fphys.2020.566410

IF: 4

2020-09-30

Frontiers in Physiology

Abstract:Increasing evidences suggest that angiotensin (Ang) II participates in the pathogenesis of endothelial dysfunction (ED) through multiple signaling pathways, including angiotensin type 1 receptor (AT1R) mediated NADPH oxidase (Nox)/reactive oxygen species (ROS) signal transduction. However, the detailed mechanism is not completely understood. In this study, we reported that AngII/AT1R-mediated activated protein phosphatase 2A (PP2A) downregulated endothelial nitric oxide synthase (eNOS) phosphorylation via Nox/ROS pathway. AngII treatment reduced the levels of phosphorylation of eNOS Ser1177 and nitric oxide (NO) content along with phosphorylation of PP2Ac (PP2A catalytic subunit) Tyr307, meanwhile increased the PP2A activity and ROS production in human umbilical vein endothelial cells (HUVECs). These changes could be impeded by AT1R antagonist candesartan (CAN). The pretreatment of 10−8 M PP2A inhibitor okadaic acid (OA) reversed the levels of eNOS Ser1177 and NO content. Similar effects of AngII on PP2A and eNOS were also observed in the mesenteric arteries of Sprague-Dawley rats subjected to AngII infusion via osmotic minipumps for 2 weeks. We found that the PP2A activity was increased, but the levels of PP2Ac Tyr307 and eNOS Ser1177 as well as NO content were decreased in the mesenteric arteries. The pretreatments of antioxidant N-acetylcysteine (NAC) and apocynin (APO) abolished the drop of the levels of PP2Ac Tyr307 and eNOS Ser1177 induced by AngII in HUVECs. The knockdown of p22phox by small interfering RNA (siRNA) gave rise to decrement of ROS production and increment of the levels of PP2Ac Tyr307 and eNOS Ser1177. These results indicated that AngII/AT1R pathway activated PP2A by downregulating its catalytic subunit Tyr307 phosphorylation, which relies on the Nox activation and ROS production. In summary, our findings indicate that AngII downregulates PP2A catalytic subunit Tyr307 phosphorylation to activate PP2A via AT1R-mediated Nox/ROS signaling pathway. The activated PP2A further decreases levels of eNOS Ser1177 phosphorylation and NO content leading to endothelial dysfunction.

physiology

What problem does this paper attempt to address?

This paper aims to explore the mechanism by which Angiotensin II (AngII) reduces endothelial nitric oxide synthase (eNOS) phosphorylation through the AT1 receptor (AT1R)-mediated NADPH oxidase (Nox)/reactive oxygen species (ROS)/protein phosphatase 2A (PP2A) signaling pathway. Specifically, the researchers focus on how AngII decreases the phosphorylation level of eNOS at the Ser1177 site by activating PP2A, thereby leading to a reduction in nitric oxide (NO) production, ultimately causing endothelial dysfunction (ED). This study not only reveals the specific molecular mechanism by which AngII affects endothelial cell function in cardiovascular diseases but also provides a theoretical basis for further development of therapeutic strategies targeting ED.

Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway

ROS and Endothelial Nitric Oxide Synthase (Enos)-Dependent Trafficking of Angiotensin II Type 2 Receptor Begets Neuronal NOS in Cardiac Myocytes.

Angiotensin Ii Downregulates Catalase Expression and Activity in Vascular Adventitial Fibroblasts Through an At1r/Erk1/2-Dependent Pathway

Redox-Sensitive Signaling by Angiotensin Ii Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase Shp-2 in Vascular Smooth Muscle Cells from Shr

Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature

Low Shear Stress Induces Endothelial Reactive Oxygen Species Via the AT1R/eNOS/NO Pathway.

Abstract 257: Oxidative Stress Induces Endothelial Dysfunction: Role of Ubiquitin-Proteasome System

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

1039 ACE2 DEFICIENCY FACILIATES ANGIOTENSIN II-MEDIATED VASCULAR PEROXYNITRITE PRODUCTION WITH ACTIVATION OF THE AKT/ENOS SIGNALING

[NADPH Oxidase-Derived Reactive Oxygen Species Involved in Angiotensin II-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells].

Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 Via ERK1/2 and AKT/PI3K Pathways

NADPH Oxidase 1 Mediates Acute Blood Pressure Response to Angiotensin II by Contributing to Calcium Influx in Vascular Smooth Muscle Cells

Angiotensin Ii Reduces Cardiac Adipor1 Expression Through At1 Receptor/Ros/Erk1/2/C-Myc Pathway

ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.

Abstract 1380: Antioxidants Decrease Neuronal Angiotensin II Type 1 Receptor in Heart Failure: Inhibition of Activator Protein 1 and Jun N-Terminal Kinase

Pi3k/Akt Signaling Pathway Plays A Role In Enhancement Of Enos Activity By Recombinant Human Angiotensin Converting Enzyme 2 In Human Umbilical Vein Endothelial Cells

The Role of NOX2-Derived Reactive Oxygen Species in the Induction of Endothelin-Converting Enzyme-1 by Angiotensin II

Angiotensin II Induces AT1 Receptor Upregulation by Oxidative Stress and Activation of AP1 and NF‐κB in Two Neuronal Cell Lines

Angiotensin II and Endothelin-1 Regulate MAP Kinases Through Different Redox-Dependent Mechanisms in Human Vascular Smooth Muscle Cells

Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells.

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.